Amgen (NASDAQ:AMGN) today announced that it will report its second quarter 2025 financial results onTuesday, August 5, 2025, after the close of theU.S.financial markets. The announcement will be followed by a conference call with the investment community at4:30 p.m. ET. Participating in the call fromAmgenwill beRobert A. Bradway, chairman and chief executive officer, and other members ofAmgen's senior management team.
Live audio of the conference call will be simultaneously broadcast over the internet and will be available to members of the news media, investors and the general public.
The webcast, as with other selected presentations regarding developments inAmgen's business given by management at certain investor and medical conferences, can be found onAmgen's website,www.amgen.com, under Investors. Information regarding presentation times, webcast availability and webcast links are noted onAmgen's Investor Relations Events Calendar. The webcast will be archived and available for replay for at least 90 days after the event.
About Amgen Amgen discovers, develops, manufactures and delivers innovative medicines to help millions of patients in their fight against some of the world's toughest diseases. More than 40 years ago, Amgen helped to establish the biotechnology industry and remains on the cutting-edge of innovation, using technology and human genetic data to push beyond what's known today. Amgen is advancing a broad and deep pipeline that builds on its existing portfolio of medicines to treat cancer, heart disease, osteoporosis, inflammatory diseases and rare diseases.
In 2024, Amgen was named one of the “World's Most Innovative Companies” by Fast Company and one of “America's Best Large Employers” by Forbes, among otherexternal recognitions. Amgen is one of the 30 companies that comprise the Dow Jones Industrial Average®, and it is also part of the Nasdaq-100 Index®, which includes the largest and most innovative non-financial companies listed on the Nasdaq Stock Market based on market capitalization.
For more information, visit Amgen.com and follow Amgen on X, LinkedIn, Instagram, YouTube and Threads.
CONTACT: Amgen, Thousand Oaks Elissa Snook, 609-251-1407 (media)Justin Claeys, 805-313-9775 (investors)
https://mma.prnewswire.com/media/213782/AMGEN_LOGO_V1.jpg
https://c212.net/c/img/favicon.png?sn=LA41151&sd=2025-07-31
View original content to download multimedia:https://www.prnewswire.com/news-releases/amgen-announces-webcast-of-2025-second-quarter-financial-results-302518785.html
SOURCE Amgen
https://rt.newswire.ca/rt.gif?NewsItemId=LA41151&Transmission_Id=202507311601PR_NEWS_USPR_____LA41151&DateId=20250731